Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials

Impact of Metformin on Cancer Biomarkers in Non-Diabetic Cancer Patients: A Systematic Review and Meta-Analysis of Clinical Trials

Introduction: Our aim was to investigate and evaluate the influence of metformin on cancer-related biomarkers in clinical trials. Methods: This systematic study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Major databases, includi...

Full description

Bibliographic Details
Main Authors: Tahereh Farkhondeh, Alireza Amirabadizadeh, Hamed Aramjoo, Silvia Llorens, Babak Roshanravan, Farhad Saeedi, Marjan Talebi, Mehdi Shakibaei, Saeed Samarghandian
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Current Oncology
Subjects:
metformin
Ki-67
cancer biomarkers
breast cancer
endometrial cancer
non-diabetic
Online Access:https://www.mdpi.com/1718-7729/28/2/134

Internet

https://www.mdpi.com/1718-7729/28/2/134

Similar Items